H. Schultheiss

发表

Transgenic overexpression of the adenine nucleotide translocase 1 protects cardiomyocytes against TGFβ1-induced apoptosis by stabilization of the mitochondrial permeability transition pore.

A. Dörner, H. Schultheiss, K. Schlüter, 2012, Journal of molecular and cellular cardiology.

Regulation of cardiomyocyte full‐length tissue factor expression and microparticle release under inflammatory conditions in vitro

W. Poller, A. Eisenreich, U. Rauch, 2009, Journal of thrombosis and haemostasis : JTH.

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

R. Ewert, H. Orzechowski, R. Wensel, 2001, Chest.

Regional analysis of inflammation and contractile function in reperfused acute myocardial infarction by in vivo 19F cardiovascular magnetic resonance in pigs

S. Kozerke, B. Ibáñez, U. Flögel, 2022, Basic Research in Cardiology.

Long‐term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor‐kappaB and activator protein 1 activation in pigs

C. Loddenkemper, H. Martens, R. Dechend, 2009, European journal of clinical investigation.

Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration

S. Morgera, R. Willers, B. Strauer, 1997, Intensive Care Medicine.

PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS)

F. Gries, D. Tschoepe, B. Strauer, 1996, European heart journal.

Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter.

H. Fechner, A. Van der Laarse, H. Wang, 2000, Circulation.

Platelet activation in diabetic cardiovascular autonomic neuropathy

D. Tschoepe, D. Ziegler, B. Schwippert, 1999, Diabetic medicine : a journal of the British Diabetic Association.

Large platelets continue to circulate in an activated state after myocardial infarction

D. Tschoepe, J. Esser, B. Strauer, 1994, European journal of clinical investigation.

Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.

H. Fechner, N. Mackman, W. Poller, 2012, Journal of molecular and cellular cardiology.

Platelet activation in diabetic microangiopathy.

D. Tschoepe, B. Schwippert, U. Rauch, 1998, Platelets.

Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury

H. Zeichhardt, V. Lindig, A. Dörner, 2006, Journal of Molecular Medicine.

Clopidogrel‐mediated reduction of circulating tissue factor in patients with stable coronary artery disease

U. Rauch, H. Schultheiss, M. Piorkowski, 2007, European journal of haematology.

Heparin-induced thrombocytopenia type II: Successful use of Orgaran (ORG 10172) in intensive care patients

A. Greinacher, D. Söhngen, B. Schwartzkopff, 1995, Intensive Care Medicine.

Highly variable expression of virus receptors in the human cardiovascular system

H. Fechner, W. Poller, M. Noutsias, 2002, Zeitschrift für Kardiologie.

Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

A. Houtsmuller, H. Fechner, X. Wang, 1999, Gene Therapy.

Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases

V. Erdmann, H. Fechner, J. Kurreck, 2004, Zeitschrift für Kardiologie.

Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

H. Fechner, J. Bergelson, H. Scherübl, 2000, Gene Therapy.

A novel tetracycline-controlled transactivator–transrepressor system enables external control of oncolytic adenovirus replication

H. Fechner, W. Hillen, H. Scherübl, 2003, Gene Therapy.

The ADP/ATP Carrier as a MitochondriaL Auto‐antigen—Facts and Perspectives

M. Klingenberg, H. Schultheiss, U. Kühl, 1986, Annals of the New York Academy of Sciences.

High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.

B. Stratmann, D. Tschoepe, U. Rauch, 2008, Diabetes Research and Clinical Practice.

Gestational regulation of the gene expression of C-type natriuretic peptide in mouse reproductive and embryonic tissue

T. Walther, M. Bader, H. Stepan, 2001, Regulatory Peptides.

Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses

C. Scheibenbogen, S. Pinkert, K. Klingel, 2014, Basic Research in Cardiology.

Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor

H. Zeichhardt, S. Pinkert, A. Dörner, 2007, Gene Therapy.

Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide

T. Walther, H. Schultheiss, H. Stepan, 2004, Biological chemistry.

Regional analysis of inflammation and contractile function in reperfused acute myocardial infarction by in vivo 19F cardiovascular magnetic resonance in pigs

S. Kozerke, B. Ibáñez, U. Flögel, 2022, Basic Research in Cardiology.

Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban

S. Pinkert, H. Fechner, S. Weger, 2007, Gene Therapy.

Catheter based intracoronary brachytherapy leads to increased platelet activation

W. Hinkelbein, P. Schwimmbeck, U. Rauch, 2004, Heart.

Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis.

H. Schultheiss, U. Kühl, H. Schultheiss, 1989, American heart journal.